QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire•15/10/2026•18:11 ET
7
Key Highlights
- ➤QuidelOrtho (QDEL) granted RSUs covering 50,323 shares to two newly hired employees.
- ➤RSUs vest in equal annual installments over three years, subject to continued employment.
- ➤Awards were issued under QuidelOrtho’s 2026 Inducement Plan pursuant to Nasdaq Rule 5635(c)(4).
QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
SAN DIEGO, Oct. 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of equity awards to two newly hired, non-executive employees (the "Inducement Grants"). The Inducement Grants were granted pursuant to the Company's 2026 Inducement Plan and as an inducement material to each employee's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Get started
Create a free account to read the full story.